Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Impact of Physical Activity Levels on Visual Field Progression in Individuals with Glaucoma
Author Affiliations & Notes
  • Je Hyun Seo
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
    Veterans Medical Research Institute, Korea Veterans Health Service, Seoul, Korea (the Republic of)
  • Takashi Nishida
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Sasan Moghimi
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Massimo Antonio Fazio
    Department of Ophthalmology and Vision Sciences, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States
  • Christopher A Girkin
    Department of Ophthalmology and Vision Sciences, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States
  • Jeffrey M Liebmann
    Bernard and Shirlee Brown Glaucoma Research Laboratory, Department of Ophthalmology, Edward S Harkness Eye Institute, New York, New York, United States
  • Linda M Zangwill
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Robert Weinreb
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Footnotes
    Commercial Relationships   Je Hyun Seo National Research Foundation of Korea, Code F (Financial Support); Takashi Nishida Topcon, Code C (Consultant/Contractor); Sasan Moghimi National Eye Institute, University of California Tobacco-Related Disease Research Program, Code F (Financial Support); Massimo Fazio Heidelberg Engineering, Topcon, Code F (Financial Support), National Eye Institute, EyeSight Foundation of Alabama, Research to Prevent Blindness, Wolfram Research, Code R (Recipient); Christopher Girkin Iridex and Topcon, Code C (Consultant/Contractor), Heidelberg Engineering, Topcon, Code F (Financial Support), National Eye Institute, EyeSight Foundation of Alabama, Research to Prevent Blindness, Code R (Recipient); Jeffrey Liebmann Alcon, Abbvie, Carl Zeiss Meditech, Genentech, Thea, Code C (Consultant/Contractor), Novartis, Research to Prevent Blindness, National Eye Institute, Research to Prevent Blindness, Code F (Financial Support); Linda Zangwill Abbvie Inc., Topcon, Code C (Consultant/Contractor), National Eye Institute, Carl Zeiss Meditec Inc., Heidelberg Engineering GmbH, Optovue Inc., Topcon Medical Systems Inc., Code F (Financial Support), Zeiss Meditec, AISight Health (co-founder), Code P (Patent); Robert Weinreb Abbvie, Aerie Pharmaceuticals, Alcon, Allergan, Amydis, Editas, Equinox, Eyenovia, Iantrek, IOPtic, Implandata, iSTAR Medical, Nicox, Santen, Tenpoint and Topcon, Code C (Consultant/Contractor), National Eye Institute, Heidelberg Engineering, Carl Zeiss Meditec, Konan Medical, Optovue, Zilia, Centervue, and Topcon, Code F (Financial Support), Toromedes, Carl Zeiss Meditec, Code P (Patent)
  • Footnotes
    Support  National Eye Institute Grants R01EY029058, R01EY034148, R01EY027510, R01EY023704, R01EY026574, P30EY022589, R01EY034146; an Unrestricted Grant from Research to Prevent Blindness (New York, NY); Bright Focus Foundation grant #2017122; The Glaucoma Foundation grant (No grant number); and Tobacco-Related Disease Research Program T31IP1511; National Research Foundation of Korea (2022R1C1C1002929). The sponsor or funding organization had no role in the design or conduct of this research.
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4046. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Je Hyun Seo, Takashi Nishida, Sasan Moghimi, Massimo Antonio Fazio, Christopher A Girkin, Jeffrey M Liebmann, Linda M Zangwill, Robert Weinreb; Impact of Physical Activity Levels on Visual Field Progression in Individuals with Glaucoma. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4046.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine the effect of physical activity (PA) levels and the rates of visual field (VF) progression in patients with primary open-angle glaucoma (POAG).

Methods : One hundred thirty-one eyes of 80 glaucoma participants from Diagnostic Innovations in Glaucoma Study and the African Descent and Glaucoma Evaluation Study who completed PA questionnaire were enrolled. PA levels were assessed by physical activity index (PAI), metabolic equivalent of task (MET)-minutes, and walking pace. Univariable and multivariable linear mixed-effect model were used to determine the effect of PA levels on the rates of 24-2 VF mean deviation (MD) change.

Results : In the univariable analysis, slower VF MD slope was found in active PAI group (mean differences of 0.30 dB/year; P=0.041) compared to inactive PAI, and in patients with higher levels PA amounts (0.14 dB/year per 1000 MET-minutes; P=0.036). However, group maintaining faster walking pace did not show significant differences, compared to those with no walking at all and casual strolling. In the multivariable analysis, each 1000 MET-minutes higher levels of PA amounts were associate with 0.15 dB/year slower VF MD slope (P=0.024).

Conclusions : Higher PA amounts was associated with slower rate of VF MD loss, suggesting that engaging in increased PA amounts may serve as protective factor for glaucoma progression.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

Table 1. Factors Influencing Rate of VF slope Decline in Univariate Linear Mixed-Model Analysis

Table 1. Factors Influencing Rate of VF slope Decline in Univariate Linear Mixed-Model Analysis

 

Figure 1. Forest Plots for Multivariable Linear Mixed Models Assessing the Effect of PA levels on the Rate of VF Loss over Time in Patients with Primary Open-Angle Glaucoma

Figure 1. Forest Plots for Multivariable Linear Mixed Models Assessing the Effect of PA levels on the Rate of VF Loss over Time in Patients with Primary Open-Angle Glaucoma

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×